The $190m venture financing of Valo Health was the medical devices industry’s top venture financing deal as total deals worth $1.14bn were announced globally in January 2021, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 42.7% over the previous month of $1.99bn and a drop of 18.6% when compared with the last 12-month average, which stood at $1.4bn.
Comparing venture financing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $936.83m. At the country level, the US topped the list in terms of deal value at $929.33m.
In terms of volumes, North America emerged as the top region for medical devices industry venture financing deals globally, followed by Asia-Pacific and then Europe.
The top country in terms of venture financing deals activity in January 2021 was the US with 24 deals, followed by the China with six and Israel with two.
In 2021, as of January, medical devices venture financing deals worth $1.14bn were announced globally, marking an increase of 2.6% year on year.
medical devices industry venture financing deals in January 2021: Top deals
The top five medical devices industry venture financing deals accounted for 56.4% of the overall value during January 2021.
The combined value of the top five medical devices venture financing deals stood at $642m, against the overall value of $1.14bn recorded for the month.
The top five medical devices industry venture financing deals of January 2021 tracked by GlobalData were:
1) Atinum Investment, HBM Healthcare Investments, Invus Public Equities, Mirae Asset Capital and Public Sector Pension Investment Board’s $190m venture financing of Valo Health
2) The $167m venture financing of Color Genomics by General Catalyst Partners, T Rowe Price Associates and Viking Global Investors
3) AV8 Ventures, Cowen Healthcare Investments, Foresite Capital Management, Illumina Ventures, Menlo Ventures, Northpond Ventures, Orbimed Advisors, Osage University Partners, Rock Springs Capital Management, Samsara BioCapital, T Rowe Price Associates and Windham Venture Partners’ $100m venture financing of Delfi Diagnostics
4) The $100m venture financing of Paige.AI by Casdin Capital and Johnson & Johnson Innovation – JJDC
5) Ally Bridge Group and Perceptive Advisors’ venture financing of IsoPlexis for $85m.